Tsuda Makoto, Mizokoshi Akito, Shigemoto-Mogami Yukari, Koizumi Schuichi, Inoue Kazuhide
Division of Biosignaling, National Institute of Health Sciences, Tokyo, Japan.
Glia. 2004 Jan 1;45(1):89-95. doi: 10.1002/glia.10308.
Neuropathic pain is an expression of pathological operation of the nervous system, which commonly results from nerve injury and is characterized by pain hypersensitivity to innocuous stimuli, a phenomenon known as tactile allodynia. The mechanisms by which nerve injury creates tactile allodynia have remained largely unknown. We report that the development of tactile allodynia following nerve injury requires activation of p38 mitogen-activated protein kinase (p38MAPK), a member of the MAPK family, in spinal microglia. We found that immunofluorescence and protein levels of the dually phosphorylated active form of p38MAPK (phospho-p38MAPK) were increased in the dorsal horn ipsilateral to spinal nerve injury. Interestingly, the phospho-p38MAPK immunofluorescence in the dorsal horn was found exclusively in microglia, but not in neurons or astrocytes. The level of phospho-p38MAPK immunofluorescence in individual microglial cells was much higher in the hyperactive phenotype in the ipsilateral dorsal horn than the resting one in the contralateral side. Intrathecal administration of the p38MAPK inhibitor, 4-(4-fluorophenyl)-2-(4-methylsulfonylphenyl)-5-(4-pyridyl)-1H-imidazole (SB203580), suppresses development of the nerve injury-induced tactile allodynia. Taken together, our results demonstrate that nerve injury-induced pain hypersensitivity depends on activation of the p38MAPK signaling pathway in hyperactive microglia in the dorsal horn following peripheral nerve injury.
神经性疼痛是神经系统病理活动的一种表现,通常由神经损伤引起,其特征是对无害刺激产生疼痛超敏反应,即触觉异常性疼痛现象。神经损伤导致触觉异常性疼痛的机制在很大程度上仍不清楚。我们报告称,神经损伤后触觉异常性疼痛的发生需要脊髓小胶质细胞中丝裂原活化蛋白激酶家族成员p38丝裂原活化蛋白激酶(p38MAPK)的激活。我们发现,在脊髓神经损伤同侧的背角中,双磷酸化活性形式的p38MAPK(磷酸化p38MAPK)的免疫荧光和蛋白水平升高。有趣的是,背角中的磷酸化p38MAPK免疫荧光仅在小胶质细胞中发现,而在神经元或星形胶质细胞中未发现。与对侧静止表型相比,同侧背角中高活性表型的单个小胶质细胞中磷酸化p38MAPK免疫荧光水平要高得多。鞘内注射p38MAPK抑制剂4-(4-氟苯基)-2-(4-甲磺酰基苯基)-5-(4-吡啶基)-1H-咪唑(SB203580)可抑制神经损伤诱导的触觉异常性疼痛的发生。综上所述,我们的结果表明,神经损伤诱导的疼痛超敏反应取决于外周神经损伤后背角中高活性小胶质细胞中p38MAPK信号通路的激活。